Arca
Skip to content

States

What each state spends on prescription drugs through Medicare and Medicaid, how its doctors prescribe compared with the rest of the country, and the life-science companies raising money there.

Drug spending, prescribing and life-science activity in each state: Medicare Part D (2024), Medicaid (2025), fundraising and attorney general cases.

Every State

Sort by spending or opioid share; each opens its page.
Alabama$5.3B$1.0B5.2%
Alaska$396M$213M3.9%
Arizona$5.4B$2.1B4.1%
Arkansas$2.7B$499M4.7%
California$27.3B$18.3B3.3%
Colorado$3.7B$1.6B4.7%
Connecticut$4.1B$2.0B2.8%
Delaware$941M$273M3.7%
District of Columbia$716M$325M2.7%
Florida$21.5B$3.3B3.5%
Georgia$9.1B$1.3B4.3%
Hawaii$997M$264M2.8%
Idaho$1.3B$590M5.0%
Illinois$9.6B$3.3B3.2%
Indiana$6.5B$2.9B4.3%
Iowa$2.4B$1.0B3.2%
Kansas$2.4B$400M4.1%
Kentucky$5.0B$2.8B4.5%
Louisiana$4.8B$2.5B4.2%
Maine$1.4B$535M3.3%
Maryland$4.5B$1.7B3.8%
Massachusetts$7.6B$2.6B2.7%
Michigan$9.8B$4.2B4.2%
Minnesota$4.3B$1.6B3.1%
Mississippi$2.7B$595M4.1%
Missouri$6.0B$2.0B3.9%
Montana$704M$356M4.4%
Nebraska$1.6B$504M3.4%
Nevada$2.0B$870M4.7%
New Hampshire$1.1B$272M3.0%
New Jersey$8.0B$2.0B2.4%
New Mexico$1.3B$674M3.9%
New York$22.9B$12.7B2.1%
North Carolina$10.2B$4.7B4.2%
North Dakota$549M$105M3.0%
Ohio$11.3B$4.8B3.3%
Oklahoma$3.3B$1.0B4.8%
Oregon$3.0B$1.0B4.7%
Pennsylvania$14.0B$5.4B2.9%
Puerto Rico$3.1B$1.4B0.6%
Rhode Island$953M$306M2.4%
South Carolina$5.2B$964M4.0%
South Dakota$699M$282M3.5%
Tennessee$7.1B$1.6B4.4%
Texas$20.1B$3.7B3.6%
Utah$1.6B$517M5.1%
Vermont$541M$178M3.2%
Virginia$6.1B$2.5B3.3%
Washington$4.8B$1.8B4.3%
West Virginia$1.9B$886M3.2%
Wisconsin$4.9B$2.1B3.3%
Wyoming$259M$43M4.6%

Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.